STAAR Surgical is trading 5.5% higher at $20.12 after announcing a share repurchase authorization of up to $50 million.
- The program was authorized on September 24, 2026, may run for twelve months, and will be funded with organic free cash flow and cash on hand.
- Shares rose as much as 2% in after-hours trading following the announcement, providing a clear company-specific catalyst for the September 25 move.